Skip to main content

New Products

  • CandyRific puts 'twist' on Mike and Ike

    NEW YORK — CandyRific is boosting Mike and Ike candy offerings with new items.

  • ProStrakan announces U.S. launch of Abstral

    BEDMINSTER, N.J. — A drug used to treat pain in cancer patients now is available in the United States.

    ProStrakan Group announced Monday the launch of Abstral (fentanyl) sublingual tablets. The tablets, which disintegrate rapidly and are placed under the tongue, treat breakthrough pain, common in one-half to two-thirds of people with cancer-related pain.

    The drug, an opioid and controlled substance, only is available through a Food and Drug Administration-mandated REMS program. The FDA approved the drug in January.

  • Report: Pepsi onto the 'next' best thing

    PURCHASE, N.Y. — Pepsi is gearing up to launch a low-calorie soft drink, according to published reports.

    The beverage maker will debut Pepsi Next, which will tout 60 calories per 12-oz. can, Beverage Digest reported last week. The beverage could be the company's way of meeting diet soda drinkers half way.

    Pepsi's portfolio of beverages includes its namesake, Pepsi Max, Pepsi Natural, Pepsi One, Pepsi Throwback and Pepsi Wild Cherry, as well as diet and caffeine-free varieties.

  • Intellipharmaceutics seeks to market generic Seroquel XR

    TORONTO — Canadian drug maker Intellipharmaceutics International is seeking approval for a generic version of a treatment for mental disorders.

    Intellipharmaceutics announced Monday that it had filed an application with the Food and Drug Administration for quetiapine fumarate extended-release tablets, a generic version of AstraZeneca’s Seroquel XR.

  • Fuze reformulates beverages

    WHITESTONE, N.Y. — Prepare for a juice drink experience that "fuses" fruity flavors and nutritional ingredients.

    Fuze said that each of its 12 flavors tout vitamins A, C and E, and also contain distinctive fruit flavors and an added nutrient commonly associated with those fruits.

    The original Fuze line consists of seven flavors:

  • Watson receives FDA approval for Nulecit

    MORRISTOWN, N.J. — The Food and Drug Administration has approved a generic treatment for iron deficiency anemia made by Watson Pharmaceuticals, Watson said Thursday.

    The drug maker announced the approval of Nulecit (sodium ferric gluconate complex in sucrose), an injectable and generic version of Sanofi-Aventis’ Ferrlecit.

    The drug is used to treat iron deficiency anemia in adults and children ages 6 years and older undergoing chronic hemodialysis and receiving supplemental epoetin therapy.

  • SheaMoisture coming to Walgreens

    AMITYVILLE, N.Y. — Sundial has announced that Walgreens has become the exclusive national drug store retail partner for its SheaMoisture hair care line and will carry the products on shelf and online, beginning April 1.

    "We are very excited to launch our newest collection at Walgreens," stated Richelieu Dennis, founder and CEO of Sundial Creations, maker of SheaMoisture. "They have been a key partner in the growth of our business and we are enthusiastic about bringing organic hair care products to such a broad consumer base."

  • Sambazon touts organic acai with orange juice

    SAN CLEMENTE, Calif. — Sambazon has added an organic acai with orange juice drink to its lineup.

    One serving of organic acai with orange juice provides consumers with 150% of the daily value of vitamin C and contains no added sugar, while delivering powerful antioxidants, healthy omegas and vibrant flavor in every sip, the company said.

    The new Sambazon beverage is available in 10.5-oz. and 32-oz. bottles for a suggested retail price of $2.99 and $7.99, respectively. Sambazon products are sold at select grocers and Whole Foods nationwide.

X
This ad will auto-close in 10 seconds